| |
 |
|
Class Information
Number: 514/54
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Carbohydrate (i.e., saccharide radical containing) doai > Polysaccharide
Description: Subject matter wherein the organic active ingredient contains more than two saccharide radicals directly or indirectly bonded together.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6121233 |
Methods for the inhibition of cancer metastasis mediated by endothelial adhesion molecules |
Sep. 19, 2000 |
| 6121250 |
Lavage solution for intestinal tract |
Sep. 19, 2000 |
| 6117425 |
Supplemented and unsupplemented tissue sealants, method of their production and use |
Sep. 12, 2000 |
| 6117850 |
Mobilization of peripheral blood precursor cells by .beta.(1,3)-glucan |
Sep. 12, 2000 |
| 6114314 |
Formulations containing hyaluronic acid |
Sep. 5, 2000 |
| 6110897 |
Antiinflammatory cell adhesion inhibitors |
Aug. 29, 2000 |
| 6106866 |
In vivo agents comprising cationic drugs, peptides and metal chelators with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivit |
Aug. 22, 2000 |
| 6107347 |
Bimodal molecular weight hyaluronate formulations and methods for using same |
Aug. 22, 2000 |
| 6107348 |
Maltohexaose and maltoheptaose-forming amylase, and its preparation and uses |
Aug. 22, 2000 |
| 6103704 |
Therapeutic methods using hyaluronic acid |
Aug. 15, 2000 |
| 6096725 |
Methods of using .alpha.Gal oligosaccharides as immune system targeting agents |
Aug. 1, 2000 |
| 6096727 |
Method for treating wounds using modified hyaluronic acid crosslinked with biscarbodiimide |
Aug. 1, 2000 |
| 6093422 |
Biocidal compositions for treating water |
Jul. 25, 2000 |
| 6090596 |
Method and means for the production of hyaluronic acid |
Jul. 18, 2000 |
| 6090793 |
Non-mitogenic substance, its preparation and use |
Jul. 18, 2000 |
| 6090794 |
Inhibition of neurofibrosarcoma growth and angiogenesis |
Jul. 18, 2000 |
| 6087342 |
Substrates having bound polysaccharides and bacterial nucleic acids |
Jul. 11, 2000 |
| 6087344 |
Formulations containing hyaluronic acid |
Jul. 11, 2000 |
| 6087345 |
Material inhibiting lipid peroxide-increase |
Jul. 11, 2000 |
| 6083927 |
Hepatic disturbance improver |
Jul. 4, 2000 |
| 6083928 |
Skin healing method |
Jul. 4, 2000 |
| 6083929 |
Extended type 1 chain glycosphingolipids as tumor-associated antigens |
Jul. 4, 2000 |
| 6083930 |
Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
Jul. 4, 2000 |
| 6083931 |
Method of inhibiting cancer metastasis |
Jul. 4, 2000 |
| 6083932 |
Pharmaceutical compositions derived from ginseng and methods of treatment using same |
Jul. 4, 2000 |
| 6083933 |
Treatment of cystitis-like symptoms with chondroitin sulfate following administration of a challenge solution |
Jul. 4, 2000 |
| 6080589 |
Neisseria meningitidis capsular polysacchride conjugates |
Jun. 27, 2000 |
| 6077836 |
Peritoneal dialysis and compositions for use therein |
Jun. 20, 2000 |
| 6075010 |
Small molecular weight ligand-hexose containing clearing agents |
Jun. 13, 2000 |
| 6075013 |
Modified low molecular weight heparin that inhibits clot associated coagulation factors |
Jun. 13, 2000 |
| 6071532 |
Synthesis of glycophospholipid and peptide-phospholipid conjugates and uses thereof |
Jun. 6, 2000 |
| 6069135 |
Use of hyaluronic acid or its derivatives to enhance delivery of therapeutic agents |
May. 30, 2000 |
| 6066341 |
Composition for the treatment of scours in calves |
May. 23, 2000 |
| 6063402 |
Purified galactomannan as an improved pharmaceutical excipient |
May. 16, 2000 |
| 6063405 |
Sustained release delivery system |
May. 16, 2000 |
| 6060429 |
Composition and method for controlling plant diseases caused by fungi |
May. 9, 2000 |
| 6060460 |
Use of betaglycan to reduce scarring |
May. 9, 2000 |
| 6060461 |
Topically applied clotting material |
May. 9, 2000 |
| 6057302 |
Sophorolipids as stimulating agent of dermal fibroblast metabolism |
May. 2, 2000 |
| 6054122 |
Supplemented and unsupplemented tissue sealants, methods of their production and use |
Apr. 25, 2000 |
| 6054428 |
Eutrophic drug compositions based on transferrin glycans |
Apr. 25, 2000 |
| 6054433 |
Methods and compositions for stimulating tissue growth and epithelial moisturization |
Apr. 25, 2000 |
| 6054443 |
Exocellular polysaccharide produced by Streptococcus thermophilus |
Apr. 25, 2000 |
| 6051560 |
Chrondroitin sulfate/sodium hyaluronate composition |
Apr. 18, 2000 |
| 6051561 |
Compounds and compositions for delivering active agents |
Apr. 18, 2000 |
| 6048515 |
Iron-containing nanoparticles with double coating and their use in diagnosis and therapy |
Apr. 11, 2000 |
| 6048532 |
Chemical composition and method for aiding the absorption, binding and elimination of undigested fat and reducing cholesterol in the human body |
Apr. 11, 2000 |
| 6048844 |
Treatment of conditions and disease |
Apr. 11, 2000 |
| 6039970 |
Process for the preparation of microspheres containing biologically active components |
Mar. 21, 2000 |
| 6036977 |
Drug preparations for treating sexual dysfunction |
Mar. 14, 2000 |
|
|
|
